HK1079786B - 尿頻或尿失禁的治療或預防劑以及具有含氮環狀取代基的嗎啡烷衍生物 - Google Patents

尿頻或尿失禁的治療或預防劑以及具有含氮環狀取代基的嗎啡烷衍生物

Info

Publication number
HK1079786B
HK1079786B HK05112093.6A HK05112093A HK1079786B HK 1079786 B HK1079786 B HK 1079786B HK 05112093 A HK05112093 A HK 05112093A HK 1079786 B HK1079786 B HK 1079786B
Authority
HK
Hong Kong
Prior art keywords
urinary
preventives
remedies
nitrogen
heterocyclic group
Prior art date
Application number
HK05112093.6A
Other languages
English (en)
Other versions
HK1079786A1 (en
Inventor
泉本直樹
河合孝治
川村邦昭
藤村森廣
駒形俊和
Original Assignee
東麗株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東麗株式會社 filed Critical 東麗株式會社
Publication of HK1079786A1 publication Critical patent/HK1079786A1/xx
Publication of HK1079786B publication Critical patent/HK1079786B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK05112093.6A 2002-10-09 2005-12-29 尿頻或尿失禁的治療或預防劑以及具有含氮環狀取代基的嗎啡烷衍生物 HK1079786B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002295616 2002-10-09
PCT/JP2003/012890 WO2004033457A1 (ja) 2002-10-09 2003-10-08 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体

Publications (2)

Publication Number Publication Date
HK1079786A1 HK1079786A1 (en) 2006-04-13
HK1079786B true HK1079786B (zh) 2010-03-12

Family

ID=32089217

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05112093.6A HK1079786B (zh) 2002-10-09 2005-12-29 尿頻或尿失禁的治療或預防劑以及具有含氮環狀取代基的嗎啡烷衍生物

Country Status (17)

Country Link
US (1) US7320984B2 (zh)
EP (1) EP1555266B1 (zh)
JP (1) JP4016986B2 (zh)
KR (1) KR101060629B1 (zh)
CN (1) CN100537573C (zh)
AU (1) AU2003272944B2 (zh)
BR (1) BR0314754A (zh)
CA (1) CA2501389C (zh)
ES (1) ES2479042T3 (zh)
HK (1) HK1079786B (zh)
IL (1) IL166944A (zh)
MA (1) MA27454A1 (zh)
MX (1) MXPA05003723A (zh)
NO (1) NO20052167L (zh)
NZ (1) NZ539199A (zh)
WO (1) WO2004033457A1 (zh)
ZA (1) ZA200502650B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7718664B2 (en) 2004-03-30 2010-05-18 Toray Industries, Inc. Anti-itching agent
TW200621785A (en) * 2004-11-04 2006-07-01 Toray Industries Analgesic
EP1864971A4 (en) * 2005-03-31 2010-02-10 Takeda Pharmaceutical PROPHYLACTIC / THERAPEUTIC AGENT AGAINST DIABETES
ES2464593T3 (es) * 2005-11-09 2014-06-03 Toray Industries, Inc. Agente terapéutico o profiláctico para trastornos funcionales digestivos
CN101340911B (zh) * 2005-12-21 2013-01-02 东丽株式会社 镇咳剂
JP5564943B2 (ja) 2007-05-21 2014-08-06 東レ株式会社 結晶性微粉化粒子
KR101510799B1 (ko) * 2007-05-21 2015-04-10 도레이 카부시키가이샤 의약 정제의 제조법
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US8829019B2 (en) * 2008-10-24 2014-09-09 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
WO2010083384A2 (en) * 2009-01-16 2010-07-22 Virginia Commonwealth University Non-peptidyl, potent, and selective mu opioid receptor antagonists
US8623888B2 (en) * 2009-07-15 2014-01-07 Mallinckrodt Llc 3-oxy-hydromorphone derivatives
CA2802295C (en) * 2010-06-11 2016-09-20 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP3458061B1 (en) * 2016-05-19 2023-01-18 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
US20210015813A1 (en) 2018-03-08 2021-01-21 Victoria Link Ltd. Treatment of demyelinating diseases
CN109970747B (zh) * 2019-05-05 2020-07-24 潍坊科技学院 一种制备10α-羟基纳呋拉啡的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
DK0577847T3 (da) * 1992-01-23 1999-06-23 Toray Industries Morphinanderivat og medicinsk anvendelse deraf
EP0663401B1 (en) 1993-07-23 2000-06-07 Toray Industries, Inc. Morphinan derivative and medicinal use
DE69631525T2 (de) 1995-03-03 2004-12-16 Endo Pharmaceuticals Inc. Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
WO2001005795A1 (fr) 1999-07-19 2001-01-25 Toray Industries, Inc. Moyens de traitement et de prevention contre la miction frequente et l'incontinence d'urine
WO2002080918A1 (fr) 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire

Also Published As

Publication number Publication date
MA27454A1 (fr) 2005-07-01
KR101060629B1 (ko) 2011-08-31
EP1555266A1 (en) 2005-07-20
JP4016986B2 (ja) 2007-12-05
NZ539199A (en) 2008-09-26
NO20052167L (no) 2005-06-16
BR0314754A (pt) 2005-07-26
ZA200502650B (en) 2006-06-28
IL166944A (en) 2010-11-30
MXPA05003723A (es) 2005-09-30
HK1079786A1 (en) 2006-04-13
WO2004033457A1 (ja) 2004-04-22
ES2479042T3 (es) 2014-07-23
AU2003272944B2 (en) 2009-11-12
CN1703415A (zh) 2005-11-30
CA2501389C (en) 2013-01-08
EP1555266A4 (en) 2006-12-06
EP1555266B1 (en) 2014-05-21
JPWO2004033457A1 (ja) 2006-04-27
CA2501389A1 (en) 2004-04-22
US20060040970A1 (en) 2006-02-23
US7320984B2 (en) 2008-01-22
AU2003272944A1 (en) 2004-05-04
CN100537573C (zh) 2009-09-09
KR20050056232A (ko) 2005-06-14

Similar Documents

Publication Publication Date Title
HK1079786A1 (en) Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
AU2003288994A1 (en) Nitrogen-containing heterocyclic compounds and medicinal use thereof
PL372395A1 (en) Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
SI1849773T1 (sl) Piperazinski derivati za zdravljenje urinske inkontinence in bolečine
ZA200500680B (en) Quinoline derivatives and their use as mycrobacterial inhibitors
AU2001271035A1 (en) Pouch for stoma and method for treating
AU2001240542A1 (en) Heterocyclic compounds and their use as parp inhibitors
HK1061854A1 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AU2002219945A1 (en) Composition and method for treating snoring
EP1792629A4 (en) PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF
HK1067362A1 (en) Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract
AU2002342707A1 (en) Combination of selected opioids with muscarine antagonists for treating urinary incontinence
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
AU7360700A (en) Methods and compositions for preventing and treating urinary tract disorders
AU2003214273A8 (en) Improved system for the treatment of stress urinary incontinence
HUP0500162A2 (en) Heterocyclic compounds useful for preventives/remedies for urinary disturbance and pharmaceutical compounds thereof
HUP0200738A3 (en) Method of the treatment of incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
GB0411143D0 (en) Connector having a bypass capacitor and method for reducing the impedance and length of a return-signal path
AU2003281205A1 (en) Remedy for urinary frequency and urinary incontinence
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
GB2401042B (en) Antitussive agent and method for making the same
GB0001565D0 (en) Dihydrofolate reductase inhibitors
IL157297A0 (en) Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
HUP0302245A3 (en) Novel m-amino-phenylimino-imidazolidine derivatives, their use and pharmaceutical compositions for treating urinary incontinence

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131008